Tuesday, October 18, 2022 from 1:15 PM to 2:45 PM PDT at Continental Ballroom 5
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-184-L01-P
Activity Type: A Knowledge-Based Activity
The Pediatrics PRN Educational Programming Committee plans to develop a session titled An Intersection of Global Crises: Pediatric Psychiatric Disorders in the Time of COVID-19. This session is aimed to address three objectives. First, this session will provide a review of psychiatric illnesses which are manifesting or progressing as a direct result of the COVID pandemic, as well as the evidence guiding approaches to pharmacologic treatments, including monitoring, escalation/de-escalation, and notable interactions and controversies. Secondly, the session will summarize existing guidelines surrounding the utilization of pharmacogenomics to direct psychiatric therapies in pediatric patients. Lastly, the session aims to describe common toxidromes associated with psychiatric medication use in pediatric patients and considerations for the management of both acute and long term clinical complications, including re-initiation and selection of alternate therapies. The target audience of this session is any pharmacist in both the inpatient and outpatient settings who care for pediatric patients that may need these therapies. It is the purpose of this session to provide the pharmacist with the knowledge and tools to appropriately address the increasing burden of psychiatric disease in pediatric patients.
 | Moderator: Brent A. Hall, Pharm.D., BCPPS
|
Learning Objectives
1. Identify pediatric psychiatric disorders which have and are increasing in frequency during the COVID-19 pandemic.
2. Review appropriate therapies and monitoring for psychiatric disease states including Anxiety, Depression and Adjustment Disorder.
3. Outline a treatment plan for a pediatric patient with pandemic-associated anxiety.
4. Summarize how pharmacogenomics can be utilized to maximize efficacy of pediatric psychiatric medications.
5. Discuss common toxidromes associated with overdose of psychiatric medications.
6. Identify appropriate management strategies for psychiatric medication overdoses.